SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended December 2024 of Rs. 14.08 million declined by -99.49% from Rs. 2762.82 millions.Net profit was down at Rs. 46.36  millions against Rs. 216.55 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -78.59%.A decline of 49.96 millions was observed in the OP in the quarter ended December 2024 from 613.57 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 14.08 2762.82 -99.49 345.70 8455.88 -95.91 12273.18 11519.57 6.54
Other Income 138.10 71.14 94.12 378.95 200.64 88.87 453.14 332.82 36.15
PBIDT 49.96 613.57 -91.86 125.50 1975.20 -93.65 2952.81 2553.74 15.63
Interest 1.14 210.54 -99.46 6.94 625.76 -98.89 510.96 921.66 -44.56
PBDT 48.82 403.03 -87.89 118.56 1349.44 -91.21 6307.75 1365.60 361.90
Depreciation 2.46 135.56 -98.19 7.12 406.29 -98.25 533.03 573.62 -7.08
PBT 46.36 267.47 -82.67 111.44 943.15 -88.18 5774.72 791.98 629.15
TAX 0.00 50.92 0.00 0.00 255.16 0.00 1590.81 367.25 333.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -108.43 233.61 -146.41
PAT 46.36 216.55 -78.59 111.44 687.99 -83.80 4183.91 424.73 885.08
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 354.83 22.21 1497.75 36.30 23.36 55.41 24.06 22.17 8.53

Ind-Swift Lab. Share Price

139.95 -4.50 (-3.12%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.30
Dr. Reddys Lab 1307.00
Cipla 1361.00
Zydus Lifesciences 940.10
Lupin 2460.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×